180 related articles for article (PubMed ID: 23534731)
1. Association between C-reactive protein and risk of cancer: a meta-analysis of prospective cohort studies.
Guo YZ; Pan L; Du CJ; Ren DQ; Xie XM
Asian Pac J Cancer Prev; 2013; 14(1):243-8. PubMed ID: 23534731
[TBL] [Abstract][Full Text] [Related]
2. C-reactive protein levels, variation in the C-reactive protein gene, and cancer risk: the Rotterdam Study.
Siemes C; Visser LE; Coebergh JW; Splinter TA; Witteman JC; Uitterlinden AG; Hofman A; Pols HA; Stricker BH
J Clin Oncol; 2006 Nov; 24(33):5216-22. PubMed ID: 17114654
[TBL] [Abstract][Full Text] [Related]
3. C-reactive protein and risk of breast cancer: A systematic review and meta-analysis.
Guo L; Liu S; Zhang S; Chen Q; Zhang M; Quan P; Lu J; Sun X
Sci Rep; 2015 May; 5():10508. PubMed ID: 26001129
[TBL] [Abstract][Full Text] [Related]
4. Plasma C-reactive protein, genetic risk score, and risk of common cancers in the Atherosclerosis Risk in Communities study.
Prizment AE; Folsom AR; Dreyfus J; Anderson KE; Visvanathan K; Joshu CE; Platz EA; Pankow JS
Cancer Causes Control; 2013 Dec; 24(12):2077-87. PubMed ID: 24036889
[TBL] [Abstract][Full Text] [Related]
5. Inflammatory biomarkers and risk of cancer in 84,000 individuals from the general population.
Allin KH; Bojesen SE; Nordestgaard BG
Int J Cancer; 2016 Oct; 139(7):1493-500. PubMed ID: 27194008
[TBL] [Abstract][Full Text] [Related]
6. C-reactive protein, interleukin-6 and the risk of colorectal cancer: a meta-analysis.
Zhou B; Shu B; Yang J; Liu J; Xi T; Xing Y
Cancer Causes Control; 2014 Oct; 25(10):1397-405. PubMed ID: 25053407
[TBL] [Abstract][Full Text] [Related]
7. Circulating C-Reactive Protein and Breast Cancer Risk-Systematic Literature Review and Meta-analysis of Prospective Cohort Studies.
Chan DS; Bandera EV; Greenwood DC; Norat T
Cancer Epidemiol Biomarkers Prev; 2015 Oct; 24(10):1439-49. PubMed ID: 26224798
[TBL] [Abstract][Full Text] [Related]
8. Associations of circulating C-reactive protein and interleukin-6 with cancer risk: findings from two prospective cohorts and a meta-analysis.
Heikkilä K; Harris R; Lowe G; Rumley A; Yarnell J; Gallacher J; Ben-Shlomo Y; Ebrahim S; Lawlor DA
Cancer Causes Control; 2009 Feb; 20(1):15-26. PubMed ID: 18704713
[TBL] [Abstract][Full Text] [Related]
9. Inflammatory Markers of CRP, IL6, TNFα, and Soluble TNFR2 and the Risk of Ovarian Cancer: A Meta-analysis of Prospective Studies.
Zeng F; Wei H; Yeoh E; Zhang Z; Ren ZF; Colditz GA; Tworoger SS; Su X
Cancer Epidemiol Biomarkers Prev; 2016 Aug; 25(8):1231-9. PubMed ID: 27277846
[TBL] [Abstract][Full Text] [Related]
10. C-reactive protein and the risk of incident colorectal cancer.
Erlinger TP; Platz EA; Rifai N; Helzlsouer KJ
JAMA; 2004 Feb; 291(5):585-90. PubMed ID: 14762037
[TBL] [Abstract][Full Text] [Related]
11. Hs-CRP and all-cause, cardiovascular, and cancer mortality risk: A meta-analysis.
Li Y; Zhong X; Cheng G; Zhao C; Zhang L; Hong Y; Wan Q; He R; Wang Z
Atherosclerosis; 2017 Apr; 259():75-82. PubMed ID: 28327451
[TBL] [Abstract][Full Text] [Related]
12. Inflammation and sudden cardiac death in a community-based population of older adults: the Cardiovascular Health Study.
Hussein AA; Gottdiener JS; Bartz TM; Sotoodehnia N; DeFilippi C; See V; Deo R; Siscovick D; Stein PK; Lloyd-Jones D
Heart Rhythm; 2013 Oct; 10(10):1425-32. PubMed ID: 23906927
[TBL] [Abstract][Full Text] [Related]
13. C-reactive protein is a predictor of prognosis in renal cell carcinoma patients receiving tyrosine kinase inhibitors: A meta-analysis.
Wang Z; Peng S; Wang A; Xie H; Guo L; Jiang N; Niu Y
Clin Chim Acta; 2017 Dec; 475():178-187. PubMed ID: 29080691
[TBL] [Abstract][Full Text] [Related]
14. A prospective follow-up study of the relationship between C-reactive protein and human cancer risk in the Chinese Kailuan Female Cohort.
Wang G; Li N; Chang S; Bassig BA; Guo L; Ren J; Su K; Li F; Chen S; Wu S; Zou Y; Dai M; Zheng T; He J
Cancer Epidemiol Biomarkers Prev; 2015 Feb; 24(2):459-65. PubMed ID: 25490990
[TBL] [Abstract][Full Text] [Related]
15. Prognostic role of C-reactive protein in breast cancer: a systematic review and meta-analysis.
Han Y; Mao F; Wu Y; Fu X; Zhu X; Zhou S; Zhang W; Sun Q; Zhao Y
Int J Biol Markers; 2011; 26(4):209-15. PubMed ID: 22139643
[TBL] [Abstract][Full Text] [Related]
16. Meta-analysis of C-Reactive Protein and Risk of Angina Pectoris.
Jia RF; Li L; Li H; Cao XJ; Ruan Y; Meng S; Wang JY; Jin ZN
Am J Cardiol; 2020 Apr; 125(7):1039-1045. PubMed ID: 32014245
[TBL] [Abstract][Full Text] [Related]
17. C-reactive protein and colorectal cancer risk: a systematic review of prospective studies.
Tsilidis KK; Branchini C; Guallar E; Helzlsouer KJ; Erlinger TP; Platz EA
Int J Cancer; 2008 Sep; 123(5):1133-40. PubMed ID: 18528865
[TBL] [Abstract][Full Text] [Related]
18. Elevated C-reactive protein in the diagnosis, prognosis, and cause of cancer.
Allin KH; Nordestgaard BG
Crit Rev Clin Lab Sci; 2011; 48(4):155-70. PubMed ID: 22035340
[TBL] [Abstract][Full Text] [Related]
19. Prognostic significance of C-reactive protein in urological cancers: a systematic review and meta-analysis.
Dai J; Tang K; Xiao W; Yu G; Zeng J; Li W; Zhang YQ; Xu H; Chen ZQ; Ye ZQ
Asian Pac J Cancer Prev; 2014; 15(8):3369-75. PubMed ID: 24870724
[TBL] [Abstract][Full Text] [Related]
20. A predictive role of C-reactive protein in colorectal cancer risk: an updated meta-analysis from 780,985 participants and 11,289 cancer cases.
Han L; Guo Y; Ren D; Hui H; Li N; Xie X
Int J Colorectal Dis; 2023 May; 38(1):121. PubMed ID: 37160817
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]